A detailed history of Headlands Technologies LLC transactions in Geron Corp stock. As of the latest transaction made, Headlands Technologies LLC holds 7,128 shares of GERN stock, worth $32,788. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,128
Previous 514 1286.77%
Holding current value
$32,788
Previous $1,000 2200.0%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$1.75 - $3.44 $11,574 - $22,752
6,614 Added 1286.77%
7,128 $23,000
Q4 2023

Feb 02, 2024

BUY
$1.74 - $2.31 $894 - $1,187
514 New
514 $1,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.74B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.